Search

everythinglearnresearchcommunity

for

Search:↓

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Baricitinib is effective as a treatment for severe hair loss.

Upadacitinib effectively treats psoriasis and lichen planus together.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Compound 4 is a promising treatment for hair loss with low toxicity.

Tofacitinib effectively treats Alopecia Areata.

Lecithin microemulsion safely delivers tetracaine hydrochloride through the skin.